High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer
Authors
Takashi Ono
Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan
Tomonori Yabuuchi
Department of Radiation Oncology, Ninohe Hospital, Iwate, Japan
Tatsuya Nakamura
Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan
Kanako Kimura
Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan
Yusuke Azami
Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan
Katsumi Hirose
Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan
Motohisa Suzuki
Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan
Hitoshi Wada
Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan
Yasuhiro Kikuchi
Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Fukushima, Japan
Kenji Nemoto
Department of Radiation Oncology, Yamagata University Faculty of Medicine, Yamagata, Japan
Language: English
Page range: 324 - 330
Submitted on: Jan 17, 2017
Accepted on: May 14, 2017
Published on: Jun 16, 2017
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2017 Takashi Ono, Tomonori Yabuuchi, Tatsuya Nakamura, Kanako Kimura, Yusuke Azami, Katsumi Hirose, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Kenji Nemoto, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.